USA S&P Global Composite PMI for Jun 52.300 vs 51.200 consensus estimate. The prior reading was 51.200.
Israel-Based Clearmind Medicine Successfully Completes Production Of CMND-100 Drug Candidate For Clinical Trial
Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve